Annual report pursuant to Section 13 and 15(d)

Nature of Operations

Nature of Operations
12 Months Ended
Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature Of Operation [Text Block]
Note 1 Nature of Operations
These financial statements represent the consolidated financial statements of AntriaBio, Inc. (“AntriaBio”), and its wholly owned operating subsidiary, AntriaBio Delaware, Inc. (“Antria Delaware”). AntriaBio, and Antria Delaware, are collectively referred to herein as the “Company”. The Company is a clinical stage biopharmaceutical Company.